vimarsana.com

Latest Breaking News On - Seiji wakao - Page 1 : vimarsana.com

Sumitomo Pharma : May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 transcript

Sumitomo Pharma Co., Ltd. Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 May 1, 2024 .

United statesHiroshi wadaMorgan stanleyFumiyoshi sakaiAstella mirabegronSeiji wakaoShinichiro muraokaKazuaki hashiguchiStephen barkerToru kimuraHidemaru yamaguchiNaoki noguchiHiroshi nomuraTokyo head officeSumitomo pharma co ltdSumitomo pharma co

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript

Christopher O Reilly: Thank you very much for joining us out of your busy schedule today for the earnings call for Second Quarter Fiscal 2023 with Takeda Pharmaceutical Company Limited.

United statesChristophe weberChristopher oreillyHidemaru yamaguchiCiti yamaguchi sanRamona sequeiraSeiji wakaoShinichiro muraokaJulie kimTakeda pharmaceutical companyTakeda pharmaceutical co ltdMorgan stanleyUnidentified company representativeAmerican college of rheumatologyGlobal portfolio divisionTakeda pharmaceutical company limited

Daiichi Sankyo Company, Limited (DSKYF) Q2 2022 Earnings Call Transcript

Daiichi Sankyo Company, Limited (OTCPK:DSKYF) Q2 2022 Results Conference Call October 31, 2022 01:30 AM ET Company Participants Sunao Manabe - Representative Director, President and CEO.

United statesHong kongSan antonioSouth koreaNaomi kumagaiSeiji wakaoHidemaru yamaguchiDaiichi sankyoWataru takasakiBristol myers squibbFumiyoshi sakaiSunao manabeKazuaki hashiguchiShinichiro muraokaHiroyuki okuzawaPharma company of the year

Daiichi Sankyo Company, Limited (DSKYF) Q1 2022 Results - Earnings Call Transcript

Daiichi Sankyo Company, Limited (OTCPK:DSKYF) Q1 2022 Earnings Conference Call July 29, 2022 2:00 AM ETCompany ParticipantsHiroyuki Okuzawa - Head, Corporate Planning and Management.

United statesHong kongMorgan stanleyNaomi kumagaiSeiji wakaoHidemaru yamaguchiDaiichi sankyoWataru takasakiDaiichi sankyo esphaFumiyoshi sakaiKazuaki hashiguchiShinichiro muraokaTasuku honjoHiroyuki okuzawaRd divisionCompany participants

Eisai Co , Ltd (ESALF) CEO Haruo Naito on Q4 2022 Results - Earnings Call Transcript

Eisai Co., Ltd. (OTCPK:ESALF) Q4 2022 Earnings Conference Call May 13, 2022 3:30 AM ET Company Participants Haruo Naito - CEO Ivan Cheung - Senior VP & President of Neurology Business.

United statesSeiji wakaoHaruo naitoHidemaru yamaguchiMotoya kohtaniIvan cheungRyohei yanagiAsia pacificTeruyuki masakaCompany participantsOncology business group presidentMedicare medicaid servicesOncology business groupEisai companyEisai co ltdNeurology business group

vimarsana © 2020. All Rights Reserved.